Hartmut Porst European Urology Supplements

Slides:

Advertisements

Similar presentations

Date of download: 5/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Efficacy and Safety of Tadalafil in Men With Erectile.

Advertisements

Viagra is used to treat men with erectile dysfunction, also called impotence. In this condition does not occur in men normal erection necessary.

ViagraViagra is used to treat men with erectile dysfunction, also called impotence. In this condition does not occur in men normal erection necessary for.

Pascal Rischmann European Urology Supplements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management Michael O’Leary European Urology Supplements

Volume 57, Issue 5, Pages (May 2010)

Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction Steven A. Kaplan,

Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double- Blind Study in Men With Diabetes Mellitus Irwin Goldstein, MD,

Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey Varant Kupelian,

Volume 70, Issue 3, Pages (September 2016)

S. Lahme, T. Götz, K.-H. Bichler European Urology

Can Low-Intensity Extracorporeal Shockwave Therapy Improve Erectile Function? A 6- Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction

John P. Mulhall, Francesco Montorsi European Urology

Volume 52, Issue 1, Pages (July 2007)

Volume 50, Issue 1, Pages (July 2006)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 56, Issue 6, Pages (December 2009)

Back to the Future: Introduction and Conclusions

Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Raymond C. Rosen, Francois Giuliano, Culley.

Retrograde Nerve-Sparing (NS) Laparoscopic Radical Prostatectomy (LRP): Technical Aspects and Early Results Jens J. Rassweiler, Marto Sugiono, Marcel.

Volume 41, Issue 2, Pages (February 2002)

A Novel Treatment of Premature Ejaculation

Volume 70, Issue 5, Pages (November 2016)

Counselling the Prostate Cancer Patient

Laurent Boccon-Gibod European Urology Supplements

Volume 55, Issue 2, Pages (February 2009)

Volume 48, Issue 2, Pages (August 2005)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 42, Issue 4, Pages (October 2002)

Volume 44, Issue 5, Pages (November 2003)

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Richard C. Harkaway European Urology Supplements

Volume 50, Issue 5, Pages (November 2006)

Volume 50, Issue 5, Pages (November 2006)

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

Volume 74, Issue 5, Pages (November 2018)

Philip Toozs-Hobson, Pallavi Latthe European Urology Supplements

The Importance of Testosterone Control in Prostate Cancer

What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006 Michel Soulié, Nicolas Mottet, Laurent Salomon, Jacques Irani,

Jacques Irani European Urology Supplements

Impact of Tamsulosin OCAS on Energy of Patients with LUTS/BPH

The Hallmarks of BPH Progression and Risk Factors

Sergio Bracarda European Urology Supplements

Volume 53, Issue 6, Pages (June 2008)

Christian Stief European Urology Supplements

New Trends in Managing the Prostate Cancer Patient

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Volume 53, Issue 5, Pages (May 2008)

The European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking Behavior John Dean

Richard Berges European Urology Supplements

Improving Flexibility and Quality of Life for Your Patients: A Must?

Profile of Silodosin European Urology Supplements

LUTS and Sexual Dysfunction: Implications for Management of BPH

Testim® Gel: Review of Clinical Data

C.G Roehrborn, T McNicholas European Urology Supplements

Manfred Wirth, Peter Iversen, David McLeod, William See

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Prospective follow-up of sexual function after elective repair of abdominal aortic aneurysms using open and endovascular techniques Monica Pettersson,

Joaquim Bellmunt European Urology Supplements

The Impact of Premature Ejaculation on Partners and Relationships

Epidemiology and Demographics of Prostatitis

Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions Ajay Nehra, MD

Jan Roigas European Urology Supplements

Does PSA Testing Influence the Natural History of Prostate Cancer?

Volume 51, Issue 5, Pages (May 2007)

Michael Marberger European Urology Supplements

IN THE TREATMENT OF ERECTILE DYSFUNCTION

Presentation transcript:

Restoring a Normal Sexual Response: The Ultimate Goal of Erectile Dysfunction Therapy Hartmut Porst European Urology Supplements Volume 1, Issue 8, Pages 19-24 (November 2002) DOI: 10.1016/S1569-9056(02)00114-8

Fig. 1 Effects of the intrinsic factors age (A) and diabetes (B), and the extrinsic factors food intake and time of dosing (C) on tadalafil pharmacokinetics. Data from [19]. European Urology Supplements 2002 1, 19-24DOI: (10.1016/S1569-9056(02)00114-8)

Fig. 2 Tadalafil 10mg increased the cumulative time of ≥55% penile rigidity (A) and the percentage of patients achieving erection (B) compared with placebo 24hours after dosing in a RigiScan® study. Data from [20]. European Urology Supplements 2002 1, 19-24DOI: (10.1016/S1569-9056(02)00114-8)

Fig. 3 Intercourse success rates with tadalafil 20mg as a function of time (postdosing interval). Based on percentages of affirmative responses to Sexual Encounter Profile question 3: “Did your erection last long enough for you to complete intercourse with ejaculation? (yes/no)”. Data from [21]. European Urology Supplements 2002 1, 19-24DOI: (10.1016/S1569-9056(02)00114-8)